Naruo Yoshimura

1.3k total citations
59 papers, 990 citations indexed

About

Naruo Yoshimura is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Naruo Yoshimura has authored 59 papers receiving a total of 990 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 44 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Naruo Yoshimura's work include Lung Cancer Treatments and Mutations (41 papers), Lung Cancer Research Studies (24 papers) and Colorectal Cancer Treatments and Studies (15 papers). Naruo Yoshimura is often cited by papers focused on Lung Cancer Treatments and Mutations (41 papers), Lung Cancer Research Studies (24 papers) and Colorectal Cancer Treatments and Studies (15 papers). Naruo Yoshimura collaborates with scholars based in Japan. Naruo Yoshimura's co-authors include Shinzoh Kudoh, Kazuhiko Nakagawa, Tatsuo Kimura, Masahiro Fukuoka, Kazuto Hirata, Shigeki Mitsuoka, Koji Takeda, Shunichi Negoro, Kaoru Matsui and Minoru Takada and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and British Journal of Cancer.

In The Last Decade

Naruo Yoshimura

56 papers receiving 970 citations

Peers

Naruo Yoshimura
Davorin Radosavljević Serbia
Jiichiro Sasaki Japan
Sander Bins Netherlands
Olga Martelli Italy
Hiroshi Wakui Japan
Shigeki Mitsuoka Japan
N. Saijo Japan
Akihiro Nishiyama Japan
Atsushi Hayata Japan
Youwei Bi United States
Davorin Radosavljević Serbia
Naruo Yoshimura
Citations per year, relative to Naruo Yoshimura Naruo Yoshimura (= 1×) peers Davorin Radosavljević

Countries citing papers authored by Naruo Yoshimura

Since Specialization
Citations

This map shows the geographic impact of Naruo Yoshimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naruo Yoshimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naruo Yoshimura more than expected).

Fields of papers citing papers by Naruo Yoshimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naruo Yoshimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naruo Yoshimura. The network helps show where Naruo Yoshimura may publish in the future.

Co-authorship network of co-authors of Naruo Yoshimura

This figure shows the co-authorship network connecting the top 25 collaborators of Naruo Yoshimura. A scholar is included among the top collaborators of Naruo Yoshimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naruo Yoshimura. Naruo Yoshimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inomata, Minehiko, Yosuke Kawashima, Ryota Saito, et al.. (2024). Comparing the Effectiveness of Afatinib and Osimertinib for Patients With PD-L1-positive EGFR-mutant Non-small Cell Carcinoma. Cancer Diagnosis & Prognosis. 4(4). 515–520.
2.
3.
4.
Akamatsu, Hiroaki, Hideyuki Harada, Shoji Tokunaga, et al.. (2018). A Phase II Study of Gefitinib With Concurrent Thoracic Radiotherapy in Patients With Unresectable, Stage III Non–small-cell Lung Cancer Harboring EGFR Mutations (WJOG6911L). Clinical Lung Cancer. 20(1). e25–e27. 18 indexed citations
5.
Sasaki, T., Takashi Seto, Takeharu Yamanaka, et al.. (2018). A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L. British Journal of Cancer. 119(6). 675–682. 28 indexed citations
6.
7.
Mitsuoka, Shigeki, Tomoya Kawaguchi, Akihito Kubo, et al.. (2016). Epidermal growth factor receptor tyrosine kinase inhibitors in previously treated advanced non-small-cell lung cancer with wild-type EGFR. Expert Opinion on Pharmacotherapy. 17(2). 193–203. 2 indexed citations
8.
Kimura, Tatsuo, Shinzoh Kudoh, Tomohiro Suzumura, et al.. (2013). Plasma RANTES, IL-10, and IL-8 levels in non–small-cell lung cancer patients treated with EGFR-TKIs. BMC Research Notes. 6(1). 139–139. 21 indexed citations
9.
Suzumura, Tomohiro, Tatsuo Kimura, Shinzoh Kudoh, et al.. (2012). Reduced CYP2D6 function is associated with gefitinib-induced rash in patients with non-small cell lung cancer. BMC Cancer. 12(1). 568–568. 40 indexed citations
10.
Yoshimura, Naruo, Tatsuo Kimura, Shigeki Mitsuoka, et al.. (2012). Dose Escalation and Feasibility Study of Amrubicin Combined With Cisplatin in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer. American Journal of Clinical Oncology. 36(2). 105–109. 1 indexed citations
11.
Masuda, Noriyuki, Shunichi Negoro, Frederick H. Hausheer, et al.. (2010). Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 67(3). 533–542. 8 indexed citations
12.
Yoshimura, Naruo, Shinzoh Kudoh, Tatsuo Kimura, et al.. (2009). Phase II Study of Docetaxel and Carboplatin in Elderly Patients with Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 4(3). 371–375. 17 indexed citations
13.
Tamura, Kenji, Kazuhiko Nakagawa, Takayasu Kurata, et al.. (2006). Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week courses. Cancer Chemotherapy and Pharmacology. 60(2). 285–293. 30 indexed citations
14.
Kudoh, Shinzoh, Tatsuo Kimura, Naruo Yoshimura, et al.. (2005). The Association of Adenocarcinoma and Hemosputum in Pulmonary Malignancies. Respiration. 72(5). 499–503.
15.
Matsui, Kaoru, Tomonori Hirashima, Takashi Nitta, et al.. (2005). A Phase I/II Study Comparing Regimen Schedules of Gemcitabine and Docetaxel in Japanese Patients with Stage IIIB/IV Non-small Cell Lung Cancer. Japanese Journal of Clinical Oncology. 35(4). 181–187. 18 indexed citations
16.
17.
Yoshimura, Naruo, Satoshi Kudoh, Toru Mukohara, et al.. (2004). Phase I/II study of cisplatin combined with weekly paclitaxel in patients with advanced non-small-cell lung cancer. British Journal of Cancer. 90(6). 1184–1189. 8 indexed citations
18.
Okamoto, Masahiko, et al.. (2002). Tacrolimus-based immunosuppression in renal transplantation: 78 experiences in a single japanese center. Transplantation Proceedings. 34(5). 1666–1667. 1 indexed citations
19.
Takeda, Koji, et al.. (2002). Phase II study of irinotecan and carboplatin for advanced non-small cell lung cancer. Lung Cancer. 38(3). 303–308. 10 indexed citations
20.
Okamoto, Masahiko, Naruo Yoshimura, Hideki Nakajima, et al.. (2000). Beneficial effect of multiple drug therapy including tacrolimus in clinical renal transplantation. Transplantation Proceedings. 32(7). 1716–1717. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Davorin Radosavljević Breakdown of academic impact, for papers by Jiichiro Sasaki Breakdown of academic impact, for papers by Sander Bins Breakdown of academic impact, for papers by Olga Martelli Breakdown of academic impact, for papers by Hiroshi Wakui Breakdown of academic impact, for papers by Shigeki Mitsuoka Breakdown of academic impact, for papers by N. Saijo Breakdown of academic impact, for papers by Akihiro Nishiyama Breakdown of academic impact, for papers by Atsushi Hayata Breakdown of academic impact, for papers by Youwei Bi
Rankless by CCL
2026